Global Phenylketonuria (PKU) Sales Market Report 2021

Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in Asia-Pacific in 2019 is about 55.06% and that of medications is about 35.28%.
Phenylketonuria (PKU) is widely used in household, hospital and other places. The household segment accounted for 71.91% of the sales market share in Asia-Pacific in 2019.
Biomarin, Mead Johnson, Abbott and Nutricia are the Top 4 players in Asia-Pacific market. They took up 71.61% of the revenue share in 2019.

Market Analysis and Insights: Global Phenylketonuria (PKU) Market
The global Phenylketonuria (PKU) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Phenylketonuria (PKU) Scope and Market Size
The global Phenylketonuria (PKU) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phenylketonuria (PKU) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Medications
Supplements
Others

Segment by Application
Household
Hospital

The Phenylketonuria (PKU) market is analysed and market size information is provided by regions (countries). Segment by Application, the Phenylketonuria (PKU) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Dr. Schär
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary
PKU Perspectives

Frequently Asked Questions